發(fā)布時(shí)間：2019-10-25
題目：Using stem cell technology and gene engineering approach to treat autoimmune disease and cancer
主講人：Laijun Lai, MD（University of Connecticut Stem Cell Institute and Department of Allied Health Sciences）
時(shí)間：2019年10月25日 15:30-17:00
地點(diǎn)：第四會(huì)議室A334
主持人：陳凌 研究員
Biography
Prof. Lai's extensive grant-funded research covers three major areas. First, using stem cell technology and gene engineering approaches to prevent or treat autoimmune diseases such as multiple sclerosis (MS). Second, developing gene engineering approaches to enhance anti-tumor immunity and treat cancer. And third, using stem cell technology to model and treat genetic diseases such as DiGeorge Syndrome (DGS). These studies have resulted in the award of two patents and numerous grants with funding exceeding $5 million from the NIH, American Cancer Society, Connecticut Regenerative Medicine Research Fund, and others.
附件下載：
